Company Type
Limited Corporation
Established
1931
Size
Large
Employees
1000+ 
Revenue
111,831 MDKK
Gross profit
94,214 MDKK
Operating Profit (EBIT)
47,248 MDKK
Profit for the Year
38,628 MDKK
Equity
51,839 MDKK

Score

Score panel requires Premium access

Rank Profit for the Year

Rank in industry
2/11,636
"Top 10%"
Rank in Denmark
6/297,179
"Top 10%"

Top management Top 3

Board Top 3

Helge Lund 1Chairman of board
Jeppe Fonager Christiansen 24Vice chairman
Stig Strøbæk 2Boardmember

Legal owners Top 3

25-33.32%Novo Holdings A/S

Rights certificate

Selskabet forpligtes ved underskrift (i) af to direktører i forening, (ii) af en direktør eller et bestyrelsesmedlem i forening med bestyrelsens formand eller næstformand eller (iii) af den samlede bestyrelse.

Company information based on CVR

NameNovo Nordisk A/S
Alternate namesNordisk Gentofte A/S, Nordisk Insulinlaboratorium A/S, Novo Industri A/S, Novo Terapeutisk Laboratorium A/S Show less
CVR24256790
AddressNovo Alle 1, 2880 Bagsværd
IndustryManufacture of pharmaceutical preparations [212000]
Established28-11-1931 (88 yr)
Company TypeLimited Corporation
Number of employees1000+ (CVR)
Advertising protectionNo
AuditorPricewaterhousecoopers Statsautoriseret Revisionspartnerselskab
Financial statement period01-01 to 31-12
Listed on stock exchangeYes
Nasdaq OMX Copenhagen NOVO B
Company capital480,000,000 DKK
490,000,000 DKK (24-04-2018 - 23-04-2019)
500,000,000 DKK (21-04-2017 - 23-04-2018)
510,000,000 DKK (18-04-2016 - 20-04-2017)
520,000,000 DKK (19-03-2015 - 17-04-2016)
530,000,000 DKK (20-03-2014 - 18-03-2015)
Articles of assoc. last24-04-2019

Member of industries

Purpose

Selskabets formål er at forske i, udvikle, producere og markedsføre farmaceutiske, medicinske og tekniske produkter og ydelser samt anden dertil knyttet virksomhed efter bestyrelsens nærmere bestemmelse. Selskabet tilstræber at drive sin virksomhed på økonomisk, miljømæssigt og socialt ansvarlig vis.

Financial Statement

 201820172016
Currency/unit000' DKK000' DKK000' DKK
Revenue
111,831,000
+0%
111,696,000
0%
111,780,000
+4%
Gross Profit
94,214,000
+0%
94,064,000
-1%
94,597,000
+3%
Profit for the Year
38,628,000
+1%
38,130,000
+1%
37,925,000
+9%
Equity
51,839,000
+4%
49,815,000
+10%
45,269,000
-4%
Total Assets
110,769,000
+8%
102,355,000
+5%
97,539,000
+6%

Map

Loading...
ad

More financial key figures and analyses?

In Bisbase Premium you get more financial key figures for both companies, groups and industries plus access to exclusive industries complied by experts. You can also create your own analyses! It only takes a minute or so - and it's free!